Scarless Laboratories, Inc.

Torrance, CA

UEI
FHLRP57QLNL7
CAGE
667S6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Woman Owned Business
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1124 W Carson St Fl 3, Torrance, CA 90502, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel peptide for enhancing diabetic wound healing R44DK131648 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $2,495,583
Anti-scar peptide for cleft LIP repair SB1DE026972 National Institute of Dental and Craniofacial Research (NIH) $2,806,469
Novel peptide-coated suture for cleft LIP and palate repair R44DE026080 National Institute of Dental and Craniofacial Research (NIH) $7,865,822
Safety and efficacy testing of novel anti-scar peptide VS corticosteroid for scar R43AR063558 National Institutes of Health $396,771
Anti-scar peptide for cleft LIP repair R44DE024692 National Institutes of Health $1,542,306

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Scarless Laboratories, Inc. registered in SAM.gov?

Yes. Scarless Laboratories, Inc.'s SAM.gov registration is active through January 14, 2027.

What is Scarless Laboratories, Inc.'s most recent federal award?

Scarless Laboratories, Inc.'s most recent federal grant award is Novel peptide for enhancing diabetic wound healing (R44DK131648), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on September 24, 2021.

On GovTribe

See Scarless Laboratories, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login